InvestorsHub Logo

TheFinalCD

05/20/20 12:23 PM

#18 RE: Letsgosilver #17

This is the email I got back from ACER after pleading for a PR (lol)


looks like the info is not new, and already public info, so now I get why the debt holders sold it off from 7.67




-----Original Message-----
From: Investors <investors@acertx.com>
To: Investors <investors@acertx.com>; hans@lifesciadvisors.com <hans@lifesciadvisors.com>
Sent: Wed, May 20, 2020 9:05 am
Subject: RE: Formal Press Release **NEEDED***

Jeremiah:



Thank you for your interest in Acer Therapeutics. The data we referenced yesterday and this morning are from publications already posted on our website and cited in our current investor presentation, which is also posted on our website, and follows last week’s press releases. The emetine data included in the publications on our website and the subject of our tweets this week are based on published in vitro data.

Please see the following links to our:



Emetine Press Release 5/11/20

https://www.acertx.com/2020/05/11/acer-therapeutics-to-develop-emetine-as-potential-covid-19-treatment-in-collaboration-with-national-center-for-advancing-translational-sciences-one-of-the-national-institutes-of-health/



Q1 Earnings Release 5/14/20

https://www.acertx.com/2020/05/14/acer-therapeutics-reports-first-quarter-2020-financial-results-and-provides-corporate-update/